These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
183 related items for PubMed ID: 2401272
1. Inhalation pharmacokinetics of 1,3-butadiene and 1,2-epoxybutene-3 in rats and mice. Laib RJ, Filser JG, Kreiling R, Vangala RR, Bolt HM. Environ Health Perspect; 1990 Jun; 86():57-63. PubMed ID: 2401272 [Abstract] [Full Text] [Related]
2. Inhalation pharmacokinetics of 1,2-epoxybutene-3 reveal species differences between rats and mice sensitive to butadiene-induced carcinogenesis. Kreiling R, Laib RJ, Filser JG, Bolt HM. Arch Toxicol; 1987 Jun; 61(1):7-11. PubMed ID: 3439877 [Abstract] [Full Text] [Related]
3. Species differences in butadiene metabolism between mouse and rat. Laib RJ, Filser JG, Kreiling R. Ann N Y Acad Sci; 1988 Jun; 534():663-70. PubMed ID: 3389683 [Abstract] [Full Text] [Related]
4. Interspecies differences in metabolism and kinetics of 1,3-butadiene, isobutene and styrene. Bolt HM. IARC Sci Publ; 1993 Jun; (127):37-44. PubMed ID: 8070883 [Abstract] [Full Text] [Related]
7. Epoxybutene-hemoglobin adducts in rats and mice: dose response for formation and persistence during and following long-term low-level exposure to butadiene. Osterman-Golkar SM, Moss O, James A, Bryant MS, Turner M, Bond JA. Toxicol Appl Pharmacol; 1998 May; 150(1):166-73. PubMed ID: 9630466 [Abstract] [Full Text] [Related]
8. Inhalation pharmacokinetics of isoprene in rats and mice. Peter H, Wiegand HJ, Filser JG, Bolt HM, Laib RJ. Environ Health Perspect; 1990 Jun; 86():89-92. PubMed ID: 2401276 [Abstract] [Full Text] [Related]
9. Somatic and germ cell effects in rats and mice after treatment with 1,3-butadiene and its metabolites, 1,2-epoxybutene and 1,2,3,4-diepoxybutane. Anderson D, Dobrzyńka MM, Jackson LI, Yu TW, Brinkworth MH. Mutat Res; 1997 Jul 14; 391(3):233-42. PubMed ID: 9268048 [Abstract] [Full Text] [Related]
12. High concentrations of butadiene epoxides in livers and lungs of mice compared to rats exposed to 1,3-butadiene. Himmelstein MW, Asgharian B, Bond JA. Toxicol Appl Pharmacol; 1995 Jun 14; 132(2):281-8. PubMed ID: 7785055 [Abstract] [Full Text] [Related]
13. In vivo doses of butadiene epoxides as estimated from in vitro enzyme kinetics by using cob(I)alamin and measured hemoglobin adducts: an inter-species extrapolation approach. Motwani HV, Törnqvist M. Toxicol Appl Pharmacol; 2014 Dec 15; 281(3):276-84. PubMed ID: 25448046 [Abstract] [Full Text] [Related]
17. Disposition of butadiene epoxides in Sprague-Dawley rats following exposures to 8000 ppm 1,3-butadiene: comparisons with tissue epoxide concentrations following low-level exposures. Thornton-Manning JR, Dahl AR, Allen ML, Bechtold WE, Griffith WC, Henderson RF. Toxicol Sci; 1998 Feb 15; 41(2):167-73. PubMed ID: 9520352 [Abstract] [Full Text] [Related]
18. Characterization of urinary metabolites from Sprague-Dawley rats and B6C3F1 mice exposed to [1,2,3,4-13C]butadiene. Nauhaus SK, Fennell TR, Asgharian B, Bond JA, Sumner SC. Chem Res Toxicol; 1996 Jun 15; 9(4):764-73. PubMed ID: 8831821 [Abstract] [Full Text] [Related]
19. Inhalation pharmacokinetics based on gas uptake studies. V. Comparative pharmacokinetics of ethylene and 1,3-butadiene in rats. Bolt HM, Filser JG, Störmer F. Arch Toxicol; 1984 Oct 15; 55(4):213-8. PubMed ID: 6517696 [Abstract] [Full Text] [Related]
20. Use of haemoglobin adducts for biomonitoring exposure to 1,3-butadiene. Osterman-Golkar SM, Bond JA, Ward JB, Legator MS. IARC Sci Publ; 1993 Oct 15; (127):127-34. PubMed ID: 8070858 [Abstract] [Full Text] [Related] Page: [Next] [New Search]